1. Xiang L, Wang M, You T, Jiao Y, Chen J, Xu W. Prognostic value of ventricularwall motion score and global registry of acute coronary events score inpatients with acute myocardial infarction. Am J Med Sci. 2017;354(1):27-32.
2. Soylu K, Gedikli Ö, Dagasan G, et al. Neutrophil-to-lymphocyte ratio predictscoronary artery lesion complexity and mortality after non-ST-segmentelevation acute coronary syndrome. Rev Port Cardiol. 2015;34(7-8):465-471.
3. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil tolymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470-476.
4. Wada H, Dohi T, Miyauchi K, et al. Pre-procedural neutrophil-to-lymphocyteratio and long-term cardiac outcomes after percutaneous coronaryintervention for stable coronary artery disease. Atherosclerosis. 2017;265:35-40.
5. Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution asdeterminants of acute coronary syndromes. Circ Res. 2014;114(12):1867-1879.
6. Libby P, Ridker PM, Hansson GK. Leducq transatlantic network on a:inflammation in atherosclerosis: from pathophysiology to practice. J AmColl Cardiol. 2009;54(23):2129-2138.
7. Donia T, Khamis A. Management of oxidative stress and inflammationin cardiovascular diseases: mechanisms and challenges. Environ SciPollut Res Int. 2021;(28):34121-34153.
8. Zhang DP, Mao XF, Wu TT, et al. The fibrinogen-to-albumin ratio isassociated with outcomes in patients with coronary artery disease whounderwent percutaneous coronary intervention. Clin Appl Thromb Hemost.2020;26:1076029620933008.
9. Farrokhi F, Smiley D, Umpierrez GE. Glycemic control in non-diabeticcritically ill patients. Best Pract Res Clin Endocrinol Metab. 2011;25(5):813-824.
10. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response!Crit Care. 2013;17(2):1-7.
11. Matano F, Fujiki Y, Mizunari T, et al. Serum glucose and potassium ratioas risk factors for cerebral vasospasm after aneurysmal subarachnoidhemorrhage. J Stroke Cerebrovasc Dis. 2019;28(7):1951-1957.
12. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia andincreased risk of death after myocardial infarction in patients with andwithout diabetes: a systematic overview. Lancet. 2000;355(9206):773-778.
13. Deedwania P, Kosiborod M, Barrett E, et al. Hyperglycemia and acutecoronary syndrome: a scientific statement from the american heartassociation diabetes committee of the council on nutrition, physical activity,and metabolism. Circulation. 2008;117(12):1610-1619.
14. Wahab NN, Cowden EA, Pearce NJ, et al. Is blood glucose an independentpredictor of mortality in acute myocardial infarction in the thrombolyticera? J Am Coll Cardiol. 2002;40(10):1748-1754.
15. Bolk J, van der Ploeg TJ, Cornel JH, Arnold AER, Sepers J, Umans VAWM.Impaired glucose metabolism predicts mortality after a myocardialinfarction. Int J Cardiol. 2001;79(2-3):207-214.
16. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S. Cardiogenic shockcomplicating acute myocardial infarction in patients without heart failure onadmission: incidence, risk factors, and outcome. Am J Med. 1993;94(3):265-273.
17. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose andmortality in elderly patients hospitalized with acute myocardial infarction:implications for patients with and without recognized diabetes. Circulation.2005;111(23):3078-3086.
18. Tsuchida K, Nishida K, Soda S, et al. Impact of glycemic variability onmyocardial infarct size in patients with ST-segment elevation myocardialinfarction: quantitative assessment of left ventricular wall motion severity.Cardiovasc Interv Ther. 2019;34(2):122-130.
19. Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucoseinfusion followed by subcutaneous insulin treatment in diabetic patientswith acute myocardial infarction (DIGAMI study): effects on mortality at 1year. J Am Coll Cardiol. 1995;26(1):57-65.
20. Melek FE, Baroncini LAV, Repka JCD, Nascimento CS, Précoma DB.Oxidative stress and inflammatory response increase during coronaryartery bypass grafting with extracorporeal circulation. Braz J CardiovascSurg. 2012;27(1):61-65.
21. Sadiq SMM, Dakhil MA, Dakhil ZA. Effect of diabetes on laboratorymarkers in patients with non-ST elevation acute coronary syndromes. J PhysConf Ser. 2021;1818(1):012040.
22. Matano F, Fujiki Y, Mizunari T, et al. Serum glucose and potassium ratioas risk factors for cerebral vasospasm after aneurysmal subarachnoidhemorrhage. J Stroke Cerebrovasc Dis. 2019;28(7):1951-1957.
23. Wu XY, Zhuang YK, Cai Y, et al. Serum glucose and potassium ratio as apredictive factor for prognosis of acute intracerebral hemorrhage. J Int MedRes. 2021;49(4):030006052110096.
24. Fujiki Y, Matano F, Mizunari T, et al. Serum glucose/potassium ratio as aclinical risk factor for aneurysmal subarachnoid hemorrhage. J Neurosurg.2018;129(4):870-875.